E.R. Koomen

421 total citations
8 papers, 320 citations indexed

About

E.R. Koomen is a scholar working on Oncology, Immunology and Dermatology. According to data from OpenAlex, E.R. Koomen has authored 8 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 2 papers in Dermatology. Recurrent topics in E.R. Koomen's work include Cutaneous Melanoma Detection and Management (4 papers), Skin Protection and Aging (2 papers) and Cancer, Lipids, and Metabolism (2 papers). E.R. Koomen is often cited by papers focused on Cutaneous Melanoma Detection and Management (4 papers), Skin Protection and Aging (2 papers) and Cancer, Lipids, and Metabolism (2 papers). E.R. Koomen collaborates with scholars based in Netherlands, Italy and United Kingdom. E.R. Koomen's co-authors include Henk‐Jan Guchelaar, Tamar Nijsten, Ron M. C. Herings, Francesco Sera, Saverio Caini, Sara Gandini, Alessandra di Pietro, Simona Iodice, Arjen Joosse and M. K. Casparie and has published in prestigious journals such as PLoS ONE, Annals of Oncology and European Journal of Cancer.

In The Last Decade

E.R. Koomen

8 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E.R. Koomen Netherlands	8	176	104	62	56	50	8	320
Sansanee Wongwaisayawan Thailand	13	204 1.2×	78 0.8×	115 1.9×	98 1.8×	68 1.4×	28	496
Erin Flores United States	7	160 0.9×	20 0.2×	102 1.6×	180 3.2×	35 0.7×	9	819
Ulrich Stocker Germany	5	220 1.3×	268 2.6×	18 0.3×	43 0.8×	126 2.5×	8	555
Rossella Di Franco Italy	11	107 0.6×	40 0.4×	87 1.4×	138 2.5×	72 1.4×	32	481
Katsuhisa Enomoto Japan	10	91 0.5×	77 0.7×	46 0.7×	70 1.3×	27 0.5×	69	342
Alexa J. Resler United States	9	126 0.7×	30 0.3×	79 1.3×	75 1.3×	76 1.5×	12	323
Pontus Berglund Sweden	9	148 0.8×	73 0.7×	71 1.1×	171 3.1×	13 0.3×	15	414
Josefina Muñoz Spain	11	69 0.4×	19 0.2×	118 1.9×	175 3.1×	43 0.9×	11	453
Rosaria Cesaraccio Italy	10	139 0.8×	30 0.3×	76 1.2×	72 1.3×	29 0.6×	14	243
Bernd Schnarr Germany	10	125 0.7×	35 0.3×	55 0.9×	159 2.8×	20 0.4×	10	530

Countries citing papers authored by E.R. Koomen

Since Specialization

Citations

This map shows the geographic impact of E.R. Koomen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.R. Koomen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.R. Koomen more than expected).

Fields of papers citing papers by E.R. Koomen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.R. Koomen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.R. Koomen. The network helps show where E.R. Koomen may publish in the future.

Co-authorship network of co-authors of E.R. Koomen

This figure shows the co-authorship network connecting the top 25 collaborators of E.R. Koomen. A scholar is included among the top collaborators of E.R. Koomen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.R. Koomen. E.R. Koomen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Simkens, Lieke H. J., Jara M. Baas, E.R. Koomen, et al.. (2014). Statin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study. PLoS ONE. 9(11). e112201–e112201. 34 indexed citations

2.

Siiskonen, Satu J., E.R. Koomen, Loes E. Visser, et al.. (2013). Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma. European Journal of Clinical Pharmacology. 69(7). 1437–1444. 22 indexed citations

3.

Holterhues, Cynthia, Loes M. Hollestein, Tamar Nijsten, et al.. (2013). Burden of disease due to cutaneous melanoma has increased in the Netherlands since 1991. British Journal of Dermatology. 169(2). 389–397. 21 indexed citations

4.

Gandini, Sara, Simona Iodice, E.R. Koomen, et al.. (2011). Hormonal and reproductive factors in relation to melanoma in women: Current review and meta-analysis. European Journal of Cancer. 47(17). 2607–2617. 97 indexed citations

5.

Koomen, E.R., Esther de Vries, Léon C.L.T. van Kempen, et al.. (2010). Epidemiology of Extracutaneous Melanoma in the Netherlands. Cancer Epidemiology Biomarkers & Prevention. 19(6). 1453–1459. 29 indexed citations

6.

Koomen, E.R., RM Herings, Henk‐Jan Guchelaar, & Tamar Nijsten. (2009). Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cancer Epidemiology. 33(5). 391–395. 20 indexed citations

7.

Koomen, E.R., Arjen Joosse, Ron M. C. Herings, et al.. (2008). Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study. Annals of Oncology. 20(2). 358–364. 61 indexed citations

8.

Koomen, E.R., Arjen Joosse, Ron M. C. Herings, et al.. (2007). Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?. European Journal of Cancer. 43(17). 2580–2589. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact